These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 34776933)

  • 41. Brain-derived tau: a novel blood-based biomarker for Alzheimer's disease-type neurodegeneration.
    Gonzalez-Ortiz F; Turton M; Kac PR; Smirnov D; Premi E; Ghidoni R; Benussi L; Cantoni V; Saraceno C; Rivolta J; Ashton NJ; Borroni B; Galasko D; Harrison P; Zetterberg H; Blennow K; Karikari TK
    Brain; 2023 Mar; 146(3):1152-1165. PubMed ID: 36572122
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Potential Utility of Plasma Biomarker Panels in Differential Diagnosis of Alzheimer's Disease.
    Krishna G; Thangaraju Sivakumar P; Dahale AB; Subramanian S
    J Alzheimers Dis Rep; 2024; 8(1):1-7. PubMed ID: 38229828
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Blood-Based ATN Biomarkers of Alzheimer's Disease: A Meta-Analysis.
    Koychev I; Jansen K; Dette A; Shi L; Holling H
    J Alzheimers Dis; 2021; 79(1):177-195. PubMed ID: 33252080
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The associations between type 2 diabetes and plasma biomarkers of Alzheimer's disease in the Health and Aging Brain Study: Health Disparities (HABS-HD).
    Yu F; Pituch KA; Maxfield M; Baena E; Geda YE; Pruzin JJ; Coon DW; Shaibi GQ;
    PLoS One; 2024; 19(4):e0295749. PubMed ID: 38558059
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.
    Olsson B; Lautner R; Andreasson U; Öhrfelt A; Portelius E; Bjerke M; Hölttä M; Rosén C; Olsson C; Strobel G; Wu E; Dakin K; Petzold M; Blennow K; Zetterberg H
    Lancet Neurol; 2016 Jun; 15(7):673-684. PubMed ID: 27068280
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma levels of phosphorylated tau and neurofilament light chain as potential biomarkers for Alzheimer's disease: A biochemical analysis in Pakistani population.
    Faraz Ahmed T; Bilal Azmi M; Imtiaz F; Zaman U; Ahmed A; Shahbaz N
    Saudi Pharm J; 2023 Jul; 31(7):1202-1209. PubMed ID: 37273267
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alzheimer's disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ
    Hampel H; Toschi N; Baldacci F; Zetterberg H; Blennow K; Kilimann I; Teipel SJ; Cavedo E; Melo Dos Santos A; Epelbaum S; Lamari F; Genthon R; Dubois B; Floris R; Garaci F; Lista S;
    Alzheimers Dement; 2018 Apr; 14(4):492-501. PubMed ID: 29328927
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association Between Plasma Apolipoprotein M With Alzheimer's Disease: A Cross-Sectional Pilot Study From China.
    Xin JY; Huang X; Sun Y; Jiang HS; Fan J; Yu NW; Guo FQ; Ye F; Xiao J; Le WD; Yang SJ; Xiang Y
    Front Aging Neurosci; 2022; 14():838223. PubMed ID: 35370599
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease.
    Mattsson N; Andreasson U; Zetterberg H; Blennow K;
    JAMA Neurol; 2017 May; 74(5):557-566. PubMed ID: 28346578
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer's disease.
    Wang MJ; Yi S; Han JY; Park SY; Jang JW; Chun IK; Kim SE; Lee BS; Kim GJ; Yu JS; Lim K; Kang SM; Park YH; Youn YC; An SSA; Kim S
    Alzheimers Res Ther; 2017 Dec; 9(1):98. PubMed ID: 29246249
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Decreased cerebrospinal fluid neuronal pentraxin receptor is associated with PET-Aβ load and cerebrospinal fluid Aβ in a pilot study of Alzheimer's disease.
    Lim B; Fowler C; Li QX; Rowe C; Dhiman K; Gupta VB; Masters CL; Doecke JD; Martins RN; Collins S; Diamandis EP
    Neurosci Lett; 2020 Jul; 731():135078. PubMed ID: 32450185
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multiplex immunoassay measurement of amyloid-β
    Vogelgsang J; Shahpasand-Kroner H; Vogelgsang R; Streit F; Vukovich R; Wiltfang J
    Exp Brain Res; 2018 May; 236(5):1241-1250. PubMed ID: 29480353
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnostic Blood Biomarkers in Alzheimer's Disease.
    Park JE; Gunasekaran TI; Cho YH; Choi SM; Song MK; Cho SH; Kim J; Song HC; Choi KY; Lee JJ; Park ZY; Song WK; Jeong HS; Lee KH; Lee JS; Kim BC
    Biomedicines; 2022 Jan; 10(1):. PubMed ID: 35052848
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of Neurofilament Light Chain as a Potential Biomarker for Alzheimer's Disease: A Correlative Meta-Analysis.
    Jin M; Cao L; Dai YP
    Front Aging Neurosci; 2019; 11():254. PubMed ID: 31572170
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma tau and neurofilament light chain as biomarkers of Alzheimer's disease and their relation to cognitive functions.
    Abed SS; Hamdan FB; Hussein MM; Al-Mayah QS
    J Med Life; 2023 Feb; 16(2):284-289. PubMed ID: 36937471
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma biomarkers predict Alzheimer's disease before clinical onset in Chinese cohorts.
    Cai H; Pang Y; Fu X; Ren Z; Jia L
    Nat Commun; 2023 Oct; 14(1):6747. PubMed ID: 37875471
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cerebrospinal Fluid Biomarkers for the Diagnosis and Classification of Alzheimer's Disease Spectrum.
    Lee J; Jang H; Kang SH; Kim J; Kim JS; Kim JP; Kim HJ; Seo SW; Na DL
    J Korean Med Sci; 2020 Nov; 35(44):e361. PubMed ID: 33200589
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The heritability of blood-based biomarkers related to risk of Alzheimer's disease in a population-based sample of early old-age men.
    Gillespie NA; Elman JA; McKenzie RE; Tu XM; Xian H; Reynolds CA; Panizzon MS; Lyons MJ; Eglit GML; Neale MC; Rissman RA; Franz C; Kremen WS
    Alzheimers Dement; 2024 Jan; 20(1):356-365. PubMed ID: 37622539
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of glial and neuronal degeneration markers with Alzheimer's disease cerebrospinal fluid profile and cognitive functions.
    Teitsdottir UD; Jonsdottir MK; Lund SH; Darreh-Shori T; Snaedal J; Petersen PH
    Alzheimers Res Ther; 2020 Aug; 12(1):92. PubMed ID: 32753068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.